Literature DB >> 11570606

Genetic polymorphisms of adrenergic receptors.

E M Garland1, I Biaggioni.   

Abstract

Recent advances in molecular biology have enhanced the understanding of adrenergic receptors. They have allowed the characterization of the several subtypes of adrenergic receptors expressed and have expanded the research about the potential physiologic functions they mediate. Furthermore, variant forms, or polymorphims, of the genes that code for these receptors are being identified. These genetic variants may or may not result in functional differences in the receptors they encode. There is obvious interest in determining the physiologic and clinical relevance of these polymorphisms. The purpose of this review is to describe these polymorphisms and the often contradictory literature pertaining to their clinical significance. Progress in this area is being made at a rapid pace. As the allele-disease relations become less equivocal, it might be possible to predict individual differences in susceptibility to a disease, disease prognosis, and response to treatment.

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2001        PMID: 11570606     DOI: 10.1007/bf02322049

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  98 in total

Review 1.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

2.  The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.

Authors:  K M O'Shaughnessy; B Fu; C Dickerson; D Thurston; M J Brown
Journal:  Clin Sci (Lond)       Date:  2000-09       Impact factor: 6.124

3.  Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.

Authors:  H G Xie; C M Stein; R B Kim; J V Gainer; G Sofowora; V Dishy; N J Brown; R E Goree; J L Haines; A J Wood
Journal:  Clin Pharmacol Ther       Date:  2000-06       Impact factor: 6.875

4.  A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.

Authors:  D A Mason; J D Moore; S A Green; S B Liggett
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

5.  The Trp64Arg amino acid polymorphism of the beta3-adrenergic receptor gene does not contribute to the genetic susceptibility of diabetic microvascular complications in Caucasian type 1 diabetic patients.

Authors:  L Tarnow; S A Urhammer; B Mottlau; B V Hansen; O Pedersen; H H Parving
Journal:  Nephrol Dial Transplant       Date:  1999-04       Impact factor: 5.992

6.  Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.

Authors:  B J Lipworth; I P Hall; I Aziz; K S Tan; A Wheatley
Journal:  Clin Sci (Lond)       Date:  1999-03       Impact factor: 6.124

7.  Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study.

Authors:  M D'amato; L R Vitiani; G Petrelli; L Ferrigno; A di Pietro; R Trezza; P M Matricardi
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

8.  Localization of messenger RNA for three distinct alpha 2-adrenergic receptor subtypes in human tissues. Evidence for species heterogeneity and implications for human pharmacology.

Authors:  D E Berkowitz; D T Price; E A Bello; S O Page; D A Schwinn
Journal:  Anesthesiology       Date:  1994-11       Impact factor: 7.892

9.  Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene.

Authors:  J Walston; K Silver; C Bogardus; W C Knowler; F S Celi; S Austin; B Manning; A D Strosberg; M P Stern; N Raben
Journal:  N Engl J Med       Date:  1995-08-10       Impact factor: 91.245

10.  Variants in the alpha2A AR adrenergic receptor gene in psychiatric patients.

Authors:  J Feng; J L Sobell; L L Heston; D Goldman; E Cook; H R Kranzler; J Gelernter; S S Sommer
Journal:  Am J Med Genet       Date:  1998-09-07
View more
  3 in total

1.  Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant.

Authors:  Kiran Bambha; W Ray Kim; Charles B Rosen; Rachel A Pedersen; Cynthia Rys; Christopher P Kolbert; Julie M Cunningham; Terry M Therneau
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

2.  Effect of propranolol as antiadhesive therapy in sickle cell disease.

Authors:  Laura M De Castro; Rahima Zennadi; Jude C Jonassaint; Milena Batchvarova; Marilyn J Telen
Journal:  Clin Transl Sci       Date:  2012-10-17       Impact factor: 4.689

3.  A cell-based functional assay using a green fluorescent protein-based calcium indicator dCys-GCaMP.

Authors:  Bin Cai; Xia Chen; Fang Liu; Jun Li; Lijuan Gu; Jason R Liu; Jay Liu
Journal:  Assay Drug Dev Technol       Date:  2014-08-08       Impact factor: 1.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.